The Catalog, Decoded
Generic Stendra (Avanafil): Reading the Catalog Listing Correctly
Not a deep pharmacology dive — just what's actually in this specific listing, and how to read it.
Avanafil is the newest of the four PDE5 inhibitors in the catalog, and it has a smaller footprint in the U.S. market than sildenafil or tadalafil — which means fewer people recognize the name "avanafil" on sight, let alone "Satendra," the trade name used on this specific listing.
What the listing actually contains
The catalog's avanafil listing is generic Satendra — avanafil, the same active compound sold as Stendra® in the U.S. As with the vardenafil listing, we're not tracking a single flagship product name and price point here the way we do for Sildatron-100 or Megalis 20; check the category page directly for current strength options and pricing.
We're deliberately not duplicating the pharmacology explainer on avanafil's onset time and mechanism here — that's a deeper clinical topic covered thoroughly elsewhere in our network. This page exists to help you read this specific catalog listing correctly, not to re-explain the drug class from scratch.
How it fits the catalog
Avanafil belongs to the same PDE5 inhibitor class as sildenafil, tadalafil, and vardenafil — meaning the same core interaction warnings apply. If you're deciding between the four options in the catalog, our brand-name decoder lays out active ingredient and strength side by side.
Before you order: like every PDE5 inhibitor in this catalog, avanafil can interact dangerously with nitrate medications. If that applies to you, or you're unsure, talk to a doctor first, or consider the Healthymale prescriber-reviewed path.
Full listing and current pricing on HealthyRXs
Ready to see how it stacks up against the rest of the catalog? Head to the full comparison table.